Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia (ZENITH)
This study is currently recruiting participants.
Verified May 2013 by Otsuka Pharmaceutical Development & Commercialization, Inc.
Study NCT01397786   Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.

First Received on July 11, 2011.   Last Updated on May 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
More general conditions related to this trial
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Interventions listed in this trial
OPC-34712
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services